Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location.
Suzuki G, Yamazaki H, Ogo E, Abe T, Hayabuchi N, Umeno H, Nakashima T, Nakamura S, Yoshida K.
Suzuki G, et al.
Anticancer Res. 2014 Jan;34(1):203-7.
Anticancer Res. 2014.
PMID: 24403463
The 5-year local control, disease-free, overall survival, and laryngeal preservation rates were 82%, 74%, 82%, and 90%, respectively. The location of a primary tumor within the supraglottis (epilarynx or elsewhere) was identified as the only factor predictive of progressio …
The 5-year local control, disease-free, overall survival, and laryngeal preservation rates were 82%, 74%, 82%, and 90%, respectively. The lo …